MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BMEA had -$9,582K decrease in cash & cash equivalents over the period. -$11,550K in free cash flow.

Cash Flow Overview

Change in Cash
-$9,582K
Free Cash flow
-$11,550K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-16,407 -50,002
Depreciation expense
427 935
Non-cash operating lease expense
117 1,557
Stock-based compensation expense
1,940 5,742
Change in fair value of warrant liability
-3,872 -227
Impairment of property and equipment
2,205 -
Prepaid expenses and other current assets
-5,641 -1,614
Other assets
-4 -615
Accounts payable
-1,828 -4,703
Accrued expenses and other current liabilities
400 1,308
Operating lease liabilities
-177 -1,718
Net cash used in operating activities
-11,550 -44,879
Purchase of property and equipment
0 0
Net cash used in investing activities
0 0
Proceeds from issuances of common stock under at the market equity offering program
0 5,032
Proceeds from issuance of common stock, common warrants and pre-funded warrants from public offerings
2,596 37,800
Payments of financing costs
628 125
Proceeds from stock option exercise and purchases under the employee stock purchase plan
0 117
Net cash provided by financing activities
1,968 42,824
Net decrease in cash, cash equivalents, and restricted cash
-9,582 -2,055
Cash and cash equivalents at beginning of period
58,648 -
Cash and cash equivalents at end of period
47,011 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Biomea Fusion, Inc. (BMEA)

Biomea Fusion, Inc. (BMEA)